FORA Capital’s Takeda Pharmaceutical TAK Stock Holding History

FORA Capital’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,583	Closed	-$239K	–	673
2022 Q1	$239K	Buy	+16,583	New	+$243K	0.04%	443
2021 Q2	–	Sell	-1,021	Closed	-$19K	–	1140
2021 Q1	$19K	Sell	1,021 -42,067	-98%	-$757K	0.01%	693
2020 Q4	$784K	Buy	43,088 +36,955	+603%	+$648K	0.12%	192
2020 Q3	$109K	Buy	+6,133	New	+$112K	0.07%	289
2020 Q1	–	Sell	-24,978	Closed	-$493K	–	1331
2019 Q4	$493K	Buy	+24,978	New	+$478K	0.05%	399

Other funds holding TAK

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FORA Capital's TAK Position: Q2 2022 in Review

FORA Capital sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 16,583 shares — an estimated $239K sold.

FORA Capital first reported a position in TAK in Q4 2019 and held it in 5 quarters. The position peaked at $784K in Q4 2020. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

FORA Capital reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
FORA Capital sold 16,583 Takeda Pharmaceutical shares in Q2 2022, an estimated $239K.
FORA Capital first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 5 quarters.
FORA Capital's Takeda Pharmaceutical position peaked at $784K in Q4 2020.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on FORA Capital's 13F filing for Q2 2022, filed 11 Aug 2022.